M E DeBakey|J U Gutterman - JoVE Visualize

Showing results (101-110 of 366) with videos related to

Pageof 37

Sort By:

FEBS Letters|November 20, 1998

p202 self-associates through a sequence conserved among the members of the 200-family proteinsD Koul, N U Obeyesekere, J U Gutterman, et al.

Cancer|December 1, 1979

Nodular malignant lymphomas: factors affecting complete response rate and survivalF Cabanillas, T Smith, G P Bodey, et al.

Annals of Surgery|February 1, 1985

Patterns of atherosclerosis and their surgical significanceM E DeBakey, G M Lawrie, D H Glaeser

JAMA|November 13, 1996

Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. 1973H E Garrett, E W Dennis, M E DeBakey

Cancer|February 1, 1987

Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.

Leukemia Research|January 1, 1986

The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.

Surgery, Gynecology & Obstetrics|March 1, 1975

Subpopulations of thymus dependent and thymus independent lymphocytes in human gut associated lymphoid tissuesG M Mavligit, A Jubert, J U Gutterman, et al.

American Journal of Hematology|September 1, 1988

Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.

Acta Haematologica|January 1, 1990

Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.

Blood|November 1, 1991

Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.

Pageof 37

Showing results (101-110 of 366) with videos related to

Sort By:

Pageof 37

FEBS Letters|November 20, 1998

p202 self-associates through a sequence conserved among the members of the 200-family proteinsD Koul, N U Obeyesekere, J U Gutterman, et al.

Cancer|December 1, 1979

Nodular malignant lymphomas: factors affecting complete response rate and survivalF Cabanillas, T Smith, G P Bodey, et al.

Annals of Surgery|February 1, 1985

Patterns of atherosclerosis and their surgical significanceM E DeBakey, G M Lawrie, D H Glaeser

JAMA|November 13, 1996

Aortocoronary bypass with saphenous vein graft. Seven-year follow-up. 1973H E Garrett, E W Dennis, M E DeBakey

Cancer|February 1, 1987

Therapy of chronic myelogenous leukemiaM Talpaz, H Kantarjian, K McCredie, et al.

Leukemia Research|January 1, 1986

The c-abl, bcr and C lambda genes are amplified in a cell line but not in the uncultured cells from a patient with chronic myelogenous leukemiaM B Blick, B S Andersson, J U Gutterman, et al.

Surgery, Gynecology & Obstetrics|March 1, 1975

Subpopulations of thymus dependent and thymus independent lymphocytes in human gut associated lymphoid tissuesG M Mavligit, A Jubert, J U Gutterman, et al.

American Journal of Hematology|September 1, 1988

Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemiaJ R Quesada, R Alexanian, R Kurzrock, et al.

Acta Haematologica|January 1, 1990

Alpha interferon dose-dependent suppression of secondary clones in a patient with Philadelphia-positive chronic myelogenous leukemiaD Claxton, H Kantarjian, R Kurzrock, et al.

Blood|November 1, 1991

Alteration in bone marrow adherent layer growth factor expression: a novel mechanism of chronic myelogenous leukemia progressionM Wetzler, R Kurzrock, D G Lowe, et al.

Pageof 37